Sarcoma Foundation of America Announces 2020 Research Grant Awards

Posts Tagged ‘osteosarcoma’

Sarcoma Foundation of America Announces 2020 Research Grant Awards

DAMASCUS, Md. – May 28, 2020 – The Sarcoma Foundation of America (SFA), an organization dedicated to increasing research and awareness for sarcoma, today announced that it has awarded three-quarters of a million dollars in research funds to deserving scientists as part of its 2020 SFA Research Grant program.  Fifteen research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the grants to the best,…  Read More »

What is Sarcoma?

Sarcoma is a rare type of cancer and typically produces malignant tumors derived from the connective tissue.  There are more than 70 sarcoma types and subtypes. Soft Tissue Sarcoma Soft tissue sarcoma broadly defines cancers that develop in the body’s soft tissues (i.e. muscles, tendons, fat, lymph vessels, blood vessels, and nerves). While these cancers are most commonly found in the head, neck, arms, legs, chest, and abdomen, they can develop anywhere in the body. There are various different types of soft tissue sarcoma, and depending on the type of soft tissue the cancer started in, the cells will look…  Read More »

Sarcoma Foundation of Announces 2017 Research Grants

  DAMASCUS, Md. – May 24, 2017 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased awareness and research for sarcoma, today announced that it has awarded $500,000 in research funds to deserving scientists at institutions across the United States as part of its 2017 SFA Research Grant program. Ten research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a rare cancer that arises in the body’s soft tissue and bone. All proposals are peer reviewed by members of the SFA Medical Advisory Board who award the…  Read More »

Medical Innovation Provides Hope to Pediatric Sarcoma Patients

 Today’s post was written by Bert E. Thomas IV, PhD, MBA, CEO of the Sarcoma Foundation of America. As I write this blog, we find ourselves in the midst of Childhood Cancer Awareness Month, a time to educate the public about the realities of childhood cancer and to draw attention to the need for more pediatric cancer research.  For the Sarcoma Foundation of America, Childhood Cancer Awareness Month is also a time to remind everyone that sarcomas are not just a cancer of adults, but also of children and young adults.  Sarcomas account for 15 – 20% of all childhood cancers, a…  Read More »

Sarcoma Foundation of America Announces 2016 Research Grant Awards

DAMASCUS, Md. – June 2, 2016 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased awareness and research for sarcoma, today announced that it has awarded $400,000 in research funds to deserving scientists at institutions across the United States as part of its 2016 SFA Research Grant program. Eight research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a rare cancer that arises in the body’s connective tissue. All proposals are peer reviewed by the SFA Medical Advisory Board who award the grants to the best, most promising…  Read More »

Meet Jonathan Yip – 2016 Courage Award Recipient

        In 2010, Jonathan Yip was diagnosed with osteosarcoma after returning from a carefree summer in China. Taking time off from his studies at Harvard, Jonathan underwent chemotherapy and surgery over the course of the next 10 months. At the end of his treatment, thanks to the dedication and expertise of his team at Memorial Sloan Kettering Cancer Center, including Dr. John Healey and Jody Roth, RN, Jonathan emerged cancer free and leg intact. A week after chemotherapy ended, bald and with a cane, Jonathan went to Washington, DC to intern at the White House National Economic…  Read More »

Sarcoma Foundation of America Announces 2015 Research Grant Awards

SARCOMA FOUNDATION OF AMERICA ANNOUNCES 2015 RESEARCH GRANT AWARDS DAMASCUS, Md. – May 28, 2015 – The Sarcoma Foundation of America (SFA), an organization dedicated to increased awareness and research for sarcoma, today announced that it has awarded $500,000 in research funds to deserving scientists at institutions across the United States as part of its 2015 SFA Research Grant program.  Ten 2015 SFA research grants, each worth $50,000, have been awarded to researchers who have made it their mission to study sarcoma, a rare cancer that arises in the body’s connective tissue. All proposals are peer reviewed by the SFA…  Read More »

Meet the Researcher – Kurt Weiss, MD

Kurt Richard Weiss, MD Assistant Professor, Department of Orthopaedic Surgery, Division of Musculoskeletal Oncology, Director of the Cancer Stem Cell Laboratory, University of Pittsburgh Medical Center 2013 Sarcoma Foundation of America Research Grant Recipient: “Investigation Of Novel Anti-Metastatic Therapy For Osteosarcoma”   PLEASE DESCRIBE THE FOCUS OF THE RESEARCH PERFORMED IN YOUR LAB.                 Although there are dozens of distinct histologic subtypes of sarcoma, they all share one deadly characteristic: the propensity to metastasize (spread) to the lungs. Indeed, pulmonary metastases are the main cause of mortality in sarcoma patients of all ages. Although the…  Read More »

New Clinical Development Program in Osteosarcoma

This past Sunday at the Sarcoma Foundation of America’s Annual Patient Educational Conference, attendees heard a very interesting presentation from Dr. Nicola Mason regarding research for a promising new therapy for osteosarcoma in canines. It was particularly exciting to learn from Dr. Mason that the preliminary data from this study shows a strong rationale to begin exploring this potential therapy in humans.  A day later, Advaxis, the biotechnology company developing this potential therapy, announced in a press release that it “intends to initiate a clinical development program with its product candidate, ADXS-cHER2, for the treatment of pediatric osteosarcoma.” To give…  Read More »

We Demand a Cure in Our Time

Back in April of this year, the 10th Anniversary Sarcoma Foundation of America Gala was held in New York, NY.  Each year during the Gala, the SFA Courage Award is presented to individuals honoring their strength and perseverance in their battle against sarcoma.  The honorees at the 2012 Gala were inspiring and their stories powerful.  One of the Courage Award recipients, Kurt Weiss, MD, spoke on behalf of the group. Though we are months past this year’s Gala, we thought that the words that Dr. Weiss spoke this past April should be shared again.  We hope you find his resolve…  Read More »